Year: 2015

Date Title
Dec 31, 2015 U.S. Food & Drug Administration Grants Orphan Drug Designation to Pluristem’s PLX-PAD Cells for Treatment of Severe Preeclampsia
Dec 21, 2015 Pluristem Reaches Agreement with Japan’s PMDA on Protocol for Final Trial Targeting Market Entry via Accelerated Pathway
Dec 17, 2015 Pluristem to Present at Phacilitate Cell & Gene Therapy World Conference in Washington DC on January 25-26, 2016
Dec 08, 2015 Pluristem and United Therapeutics End Licensing Agreement; Report Positive Data in Pulmonary Arterial Hypertension
Dec 03, 2015 Pluristem Signs MOU for Collaboration with Fukushima Medical University to Study PLX-R18 in Acute Radiation Syndrome
Nov 24, 2015 Pluristem to Present at Global Scientific & Investment Conferences in December
Nov 17, 2015 Pluristem to Present New Data on PLX-R18 at American Society of Hematology’s Annual Meeting
Nov 09, 2015 Pluristem Provides Corporate and Financial Highlights for First Quarter of its Fiscal Year
Oct 27, 2015 Pluristem to Participate in Three European Life Sciences Conferences in November
Oct 12, 2015 Pluristem & Charité Expand Cooperation Agreement to Include Orthopedic Indications
Oct 07, 2015 Pluristem CEO Zami Aberman Elected to Board of Directors of the Alliance for Regenerative Medicine
Sep 21, 2015 Pluristem and NIAID Met with U.S. FDA and Agreed on Development Plan for Initiation of Pivotal Study of PLX-R18 in the Treatment of Acute Radiation Syndrome
Sep 10, 2015 Pluristem provides Corporate and Financial Highlights for Fiscal Year 2015
Sep 09, 2015 Pluristem Completed Successful Meeting with the U.S. FDA in Preparation for Filing an IND for PLX-R18 to Treat Incomplete Hematopoietic Recovery after Bone Marrow Transplantation
Sep 06, 2015 Pluristem President Yaky Yanay Elected as Co-Chairman of Israel Advanced Technology Industries
Aug 17, 2015 Pluristem Granted U.S. Patent for Production Methods and Use of Placental Cell Therapy in a Range of Indications
Aug 12, 2015 Japan Grants Safety Clearance to Pluristem’s PLX-PAD Cells for Use in Clinical Trials
Aug 10, 2015 Pluristem in Key Discussions with Europe’s Adaptive Pathways Group on Phase II Protocol in Critical Limb Ischemia
Jul 27, 2015 New Data Show Pluristem’s PLX Cells Regulate the Immune System
Jun 25, 2015 Pluristem Therapeutics Announces Pricing of Registered Direct Offering of Common Stock and Warrants
Jun 24, 2015 Pluristem Granted Australian Patent for 3D Cell Expansion Technology & Use of PLX Cells in Broad Range of Indications
Jun 17, 2015 Pluristem Awarded $2.9 Million Grant by Israeli Government
Jun 03, 2015 Pluristem Awarded Grant from Israel’s Ministry of Economy for Marketing its PLX Cell Therapy in Japan
Jun 01, 2015 Pluristem Granted Key Cell Patents in Asia, Russia, Mexico, and Israel
May 27, 2015 Pluristem to Present at the International Congress of Radiation Research and Chair Two Panels at the Annual Meeting of the International Society for Cellular Therapy
May 25, 2015 Pluristem issues letter to shareholders
May 19, 2015 Pluristem to Conduct Conference at Tel Aviv Stock Exchange to Review Regulatory Progress and Company Strategy
May 18, 2015 Significant Progress for Pluristem: PLX Cells Were Selected for European Medicines Agency’s Adaptive Pathways Pilot Project
May 13, 2015 Pluristem’s PLX Cells One Step Closer to Entering Japan’s Accelerated Pathway for Regenerative Medicine
May 06, 2015 Pluristem Granted European Patent for Use of Cells to Help Treat Damaged Bone Marrow
May 04, 2015 Pluristem to Present at Five Industry and Finance Conferences in May
Apr 20, 2015 Pluristem’s Clinical Advisory Board Prepares Phase II Clinical Trials in Critical Limb Ischemia in Europe and Japan
Mar 24, 2015 Pluristem Announces Key Strategic Objectives for Development of PLX-R18 in Hematopoietic Indications
Mar 09, 2015 Pluristem to Present Data at Regenerative Medicine Conferences in Japan and South Korea
Mar 03, 2015 Pluristem and Hadassah Medical Center Announce Significant Data Showing PLX-R18 Cells Improve Bone Marrow Transplantation
Feb 18, 2015 Significant Findings in U.S. National Institutes of Health’s Trial of Pluristem’s PLX-R18 Cells for Treatment of Acute Radiation Syndrome
Feb 02, 2015 Pluristem Announces Significant New Finding from its Phase I/II Muscle Injury Trial and Excellent Safety Profile for PLX-PAD Cells at Twelve Months
Jan 13, 2015 Pluristem to Present at Two Cell Therapy Conferences in January 2015
Jan 12, 2015 Pluristem Issues Letter to Shareholders
Jan 06, 2015 Pluristem Granted Patent for Foundational Cell Harvesting Technology in South Africa